4

OWNERSHIP DOCUMENT

Company: Matinas BioPharma Holdings, Inc.
Filed: April 3, 2019
Period of Report: March 31, 2019
Accession Number: 0000905718-19-000327

View Document ↗ View on SEC.gov ↗